{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:27:29Z","timestamp":1750307249200,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":27,"publisher":"ACM","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,11,11]]},"DOI":"10.1145\/1882992.1883070","type":"proceedings-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T14:38:38Z","timestamp":1289572718000},"page":"492-496","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging the semantic web and natural language processing to enhance drug-mechanism knowledge in drug product labels"],"prefix":"10.1145","author":[{"given":"Richard","family":"Boyce","sequence":"first","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}]},{"given":"Henk","family":"Harkema","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}]},{"given":"Mike","family":"Conway","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}]}],"member":"320","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"e_1_3_2_1_1_1","unstructured":"Amgen. SENSIPAR (cinacalcet hydrochloride) tablet coated. FDA-approved drug product labeling 122008. Last accessed on DailyMed 06\/29\/2009.  Amgen. SENSIPAR (cinacalcet hydrochloride) tablet coated. FDA-approved drug product labeling 122008. Last accessed on DailyMed 06\/29\/2009."},{"key":"e_1_3_2_1_2_1","unstructured":"Apotex. fluconazole (fluconazole) solution. FDA-approved drug product labeling 01 2007. Lastaccessed on DailyMed 05\/22\/2010.  Apotex. fluconazole (fluconazole) solution. FDA-approved drug product labeling 01 2007. Lastaccessed on DailyMed 05\/22\/2010."},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1109\/TITB.2007.890842"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2009.05.001"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2009.05.010"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1006\/jbin.2001.1029"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528010-00005"},{"key":"e_1_3_2_1_8_1","first-page":"0309102685","article-title":"Preventing medication errors. Technical report","author":"Committee on Identifying and Preventing Medication Errors","year":"2006","journal-title":"Institute of Medicine"},{"volume-title":"DC: US Government Printing Office","year":"2010","author":"Congress U.","key":"e_1_3_2_1_9_1"},{"volume-title":"DC: US Government Printing Office","year":"2010","author":"Congress U.","key":"e_1_3_2_1_10_1"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-374"},{"key":"e_1_3_2_1_12_1","unstructured":"G.D.-Searle-LLC. COVERA-HS (verapamil hydrochloride) tablet extended release. FDA-approved drug product labeling 04 2010. Lastaccessed on Daily Med 05\/22\/2010.  G.D.-Searle-LLC. COVERA-HS (verapamil hydrochloride) tablet extended release. FDA-approved drug product labeling 04 2010. Lastaccessed on Daily Med 05\/22\/2010."},{"key":"e_1_3_2_1_13_1","unstructured":"Global-Pharmaceuticals. GEMFIBROZIL tablet coated. FDA-approved drug product labeling 092009. Last accessed on DailyMed 05\/22\/2010.  Global-Pharmaceuticals. GEMFIBROZIL tablet coated. FDA-approved drug product labeling 092009. Last accessed on DailyMed 05\/22\/2010."},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.09.018"},{"key":"e_1_3_2_1_15_1","unstructured":"Internal. FDA guideline: Drug interaction studies - study design data analysis and implications for dosing and labeling. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072101. pdf Sept. 2006. Last Accessed: 03\/31\/2010.  Internal. FDA guideline: Drug interaction studies - study design data analysis and implications for dosing and labeling. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072101. pdf Sept. 2006. Last Accessed: 03\/31\/2010."},{"key":"e_1_3_2_1_16_1","unstructured":"IVAX. cimetidine (Cimetidine) tablet film coated. FDA-approved drug product labeling 08 2008. Last accessed on DailyMed 12\/28\/2009.  IVAX. cimetidine (Cimetidine) tablet film coated. FDA-approved drug product labeling 08 2008. Last accessed on DailyMed 12\/28\/2009."},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1652"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241030-00001"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.5555\/1572340.1572363"},{"key":"e_1_3_2_1_20_1","unstructured":"Mutual. PROPAFENONE HYDROCHLORIDE tablet film coated. FDA-approved drug product labeling 07 2009. Last accessed on DailyMed 05\/15\/2010.  Mutual. PROPAFENONE HYDROCHLORIDE tablet film coated. FDA-approved drug product labeling 07 2009. Last accessed on DailyMed 05\/15\/2010."},{"key":"e_1_3_2_1_21_1","unstructured":"Mylan. cimetidine (Cimetidine) tablet film coated. FDA-approved drug product labeling 07 2007. Last accessed on DailyMed 12\/28\/2009.  Mylan. cimetidine (Cimetidine) tablet film coated. FDA-approved drug product labeling 07 2007. Last accessed on DailyMed 12\/28\/2009."},{"key":"e_1_3_2_1_22_1","unstructured":"S. H. Preskorn. How drug-drug interactions can impact managed care. The American Journal of Managed Care 10(6 Suppl): S186--S198 July 2004.  S. H. Preskorn. How drug-drug interactions can impact managed care. The American Journal of Managed Care 10(6 Suppl): S186--S198 July 2004."},{"key":"e_1_3_2_1_23_1","unstructured":"Teva. trimethoprim (Trimethoprim) tablet. FDA-approved drug product labeling 06 2008. Last accessed on DailyMed 05\/22\/2010.  Teva. trimethoprim (Trimethoprim) tablet. FDA-approved drug product labeling 06 2008. Last accessed on DailyMed 05\/22\/2010."},{"key":"e_1_3_2_1_24_1","unstructured":"Teva Pharmaceuticals. fluconazole (fluconazole) Teva. FDA-approved drug product labeling 10 2006. Last accessed on DailyMed 05\/22\/2010.  Teva Pharmaceuticals. fluconazole (fluconazole) Teva. FDA-approved drug product labeling 10 2006. Last accessed on DailyMed 05\/22\/2010."},{"key":"e_1_3_2_1_25_1","unstructured":"Watson. mexiletine hcl (Mexiletine hydrochloride) capsule. FDA-approved drug product labeling 04 2008. Last accessed on DailyMed 05\/22\/2010.  Watson. mexiletine hcl (Mexiletine hydrochloride) capsule. FDA-approved drug product labeling 04 2008. Last accessed on DailyMed 05\/22\/2010."},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","unstructured":"D. S. Wishart C. Knox A. C. Guo S. Shrivastava M. Hassanali P. Stothard Z. Chang and J. Woolsey. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue): D668--D672 2006.  D. S. Wishart C. Knox A. C. Guo S. Shrivastava M. Hassanali P. Stothard Z. Chang and J. Woolsey. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue): D668--D672 2006.","DOI":"10.1093\/nar\/gkj067"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70048-2"}],"event":{"name":"IHI '10: ACM International Health Informatics Symposium","sponsor":["SIGHIT ACM Special Interest Group on Health Informatics"],"location":"Arlington Virginia USA","acronym":"IHI '10"},"container-title":["Proceedings of the 1st ACM International Health Informatics Symposium"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/1882992.1883070","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/1882992.1883070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T10:52:12Z","timestamp":1750243932000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/1882992.1883070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":27,"alternative-id":["10.1145\/1882992.1883070","10.1145\/1882992"],"URL":"https:\/\/doi.org\/10.1145\/1882992.1883070","relation":{},"subject":[],"published":{"date-parts":[[2010,11,11]]},"assertion":[{"value":"2010-11-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}